BBOTVSGTBP• 6 Months (Normalized)
BBOT vs GTBP (BridgeBio Oncology Therapeutics Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Apr 5 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-56.34%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
GTBP Performance $6.1
+1270.79%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1327.13 pts
GTBP outperforming by 1327.13 percentage points
BBOTGTBP
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | BBOT Price | BBOT Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -56.34% | $6.10 | +1270.79% | -1327.13% |
| Sep 30, 2026 | $4.10 | -53.98% | $- | - | |
| Sep 29, 2026 | $3.92 | -56.00% | $6.88 | +1444.94% | -1500.94% |
| Sep 28, 2026 | $3.81 | -57.24% | $6.80 | +1428.09% | -1485.33% |
| Sep 25, 2026 | $3.95 | -55.67% | $6.89 | +1448.31% | -1503.98% |
| Sep 24, 2026 | $3.99 | -55.22% | $6.83 | +1434.83% | -1490.05% |
| Sep 23, 2026 | $4.16 | -53.31% | $7.10 | +1495.51% | -1548.82% |
| Sep 22, 2026 | $4.66 | -47.70% | $- | - | |
| Sep 21, 2026 | $4.66 | -47.70% | $7.18 | +1513.48% | -1561.18% |
| Sep 18, 2026 | $4.77 | -46.46% | $7.16 | +1508.99% | -1555.45% |
| Sep 17, 2026 | $4.89 | -45.12% | $7.49 | +1583.15% | -1628.27% |
| Sep 16, 2026 | $4.76 | -46.58% | $7.81 | +1655.06% | -1701.64% |
| Sep 15, 2026 | $4.88 | -45.23% | $9.00 | +1922.47% | -1967.70% |
| Sep 14, 2026 | $5.05 | -43.32% | $11.63 | +2513.48% | -2556.80% |
| Sep 11, 2026 | $4.95 | -44.44% | $8.61 | +1834.83% | -1879.27% |
Page 1 of 9